A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
6d
Interesting Engineering on MSNNew hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 yearsThe U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
6d
Zacks Investment Research on MSNGSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract InfectionGSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract ...
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...
6d
Pharmaceutical Technology on MSNFDA approves GSK’s Blujepa for uncomplicated UTIsThe FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...
TUESDAY, March 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women ...
The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...
GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved Blujepa for the treatment of female adults and pediatric ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results